메뉴 건너뛰기
American Journal of Surgical Pathology
Volumn 33, Issue 11, 2009, Pages 1739-1740
In response
Author keywords

[No Author keywords available]
Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EID: 70350450350     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181b7289b     Document Type: Letter
Times cited : (1)
References (3)
  • 1
    • 0037382283 scopus 로고    scopus 로고
    • Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome
    • Camp RL, Dolled-Filhart M, King BL, et al. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res. 2003;63:1445-1448.
    • (2003) Cancer Res , vol.63 , pp. 1445-1448
    • Camp, R.L.1    Dolled-Filhart, M.2    King, B.L.3
  • 2
    • 65449173170 scopus 로고    scopus 로고
    • Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer
    • Gilcrease MZ, Woodward WA, Nicolas MM, et al. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer. Am J Surg Pathol. 2009;33:759-767.
    • (2009) Am J Surg Pathol , vol.33 , pp. 759-767
    • Gilcrease, M.Z.1    Woodward, W.A.2    Nicolas, M.M.3
  • 3
    • 56549090049 scopus 로고    scopus 로고
    • New cutpoints to identify increased HER2 copy number: Analysis of a large, population-based cohort with long-term follow-up
    • Jensen KC, Turbin DA, Leung S, et al. New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up. Breast Cancer Res Treat. 2008;112: 453-459.
    • (2008) Breast Cancer Res Treat , vol.112 , pp. 453-459
    • Jensen, K.C.1    Turbin, D.A.2    Leung, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.